Do you want to read an article? Please log in or register.
Glucagon-Like Peptide (GLP-1) Receptor Agonists in Inflammatory Bowel Disease: Mechanisms, Clinical Implications, and Therapeutic Potential
Inflammatory Bowel Disease
Related content
Colonoscopy
Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy: A Systematic Review and Meta-Analysis
Am J Gastroenterol
Beran A, Nayfeh T, Akhras A, Ramai D, Mohamed M, Guardiola JJ, Al-Haddad M, Rex DK
doi: 10.14309/ajg.0000000000003362
RECOMMENDED
Inflammatory Bowel Disease
Incidence, disease burden and clinical presentation of patients newly diagnosed with inflammatory bowel disease in a population-based inception cohort
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Attauabi M, Madsen GR, Bendtsen F, Seidelin JB, Burisch J
doi: 10.1093/ecco-jcc/jjae176
Inflammatory Bowel Disease
Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City
Inflamm Bowel Dis
Klein S, Sivasailam B, Alizadeh M, Malter L, Axelrad JE
doi: 10.1093/ibd/izaf174
Inflammatory Bowel Disease
Corticosteroid Use in Randomized Clinical Trials of Biologics and Small Molecules in Inflammatory Bowel Disease: A Systematic Review
Inflamm Bowel Dis
da Silva BC, Papasotiriou S, Hanauer SB
doi: 10.1093/ibd/izae240
Further Publications
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?
J Clin Med
Chang MG, Ripoll JG, Lopez E, Krishnan K, Bittner EA
doi: 10.3390/jcm13216336
RECOMMENDED
Further Publications
The Patients Included in Clinical Trials of Biological Drugs for Inflammatory Bowel Disease Do Not Represent the Real-World Population
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Deza DC, Domínguez CL, Oliver AP, Cuadro CP, Caballero CY, Michelena LA, Esteban AR, Gracia AC, Lidón RV, Roche PC, Usán EC, Sirbu VS, Ruiz CP, López SG
doi: 10.14309/ajg.0000000000003670
Inflammatory Bowel Disease
Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
Inflamm Bowel Dis
Dulai PS, Johnson E, Cox K, Eldasher LM, Theriault N
doi: 10.1093/ibd/izae270
Inflammatory Bowel Disease
Improvement in Serum Eosinophilia is Observed in Clinical Responders to Ustekinumab but not Adalimumab in Inflammatory Bowel Disease
J Crohns Colitis
Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N
doi: 10.1093/ecco-jcc/jjaf006
RECOMMENDED
Inflammatory Bowel Disease
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology
Hanžel J, Solitano V, Vuyyuru SK, Panaccione R, Sands BE, Peyrin-Biroulet L, Danese S, D'Haens GR, Atreya R, Allez M, Bernstein CN, Bossuyt P, Bressler B, Bryant RV, Cohen BL, Colombel JF, D'Amico F, Dignass A, Dubinsky M, Fleshner P, Gearry RB, Hanauer SB, Hart AL, Kayal M, Kucharzik T, Lakatos PL, Louis E, Magro F, Narula N, Leong RW, Panés J, Raine T, Ran Z, Regueiro MD, Reinisch W, Singh S, Steinhart AH, Travis S, Ungaro RC, Janneke van der Woude C, Yamamoto T, Ahuja V, Rubin DT, Dulai PS, Cornfield LJ, Hogan M, Sandborn WJ, Feagan BG, Jairath V, Ma C
doi: 10.1053/j.gastro.2025.05.015